Posted on September 24, 2018
When it comes to healthcare, minority groups, including women and people of color, are often underserved. This is especially true of the global epidemic of heart failure (HF). There are startling disparities in the quality of care in HF and in outcomes of disease among racial and ethnic subgroups vs. the general population—and the problem is compounded by the reality that women and ethnic minorities have been grossly underrepresented in clinical trials.